Linköping University Hospital is a university hospital in Linköping, Sweden, operated by Östergötland County. Its scientific activities are integrated into the medical faculty of Linköping University. The hospital has all specializations except organ transplantation.

During the past decade, Universitetssjukhuset i Linköping conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 10 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 4 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitetssjukhuset i Linköping" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Karolinska Institutet" with 3 trials sponsored, "Uppsala University" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitetssjukhuset i Linköping" #1 collaborator was "Oslo University Hospital" with 3 trials as a collaborator, "Göteborg University" with 2 trials as a collaborator, "Haukeland University Hospital" with 2 trials as a collaborator, "Helse Stavanger HF" with 2 trials as a collaborator and "Odense University Hospital" with 2 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 87 trials.

According to Clinical.Site data, the most researched conditions in "Universitetssjukhuset i Linköping" are "Multiple Myeloma" (3 trials), "Atrial Fibrillation" (2 trials), "Cancer" (2 trials), "Pregnancy" (2 trials) and "Type 1 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Universitetssjukhuset i Linköping" in a lesser frequency.

Most popular intervention types in "Universitetssjukhuset i Linköping" are "Drug" (30 trials), "Other" (6 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (4 trials), "Placebo" (4 trials), "Atezolizumab" (3 trials), "Cyclophosphamide" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitetssjukhuset i Linköping" are 46 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Universitetssjukhuset i Linköping". undefined are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Universitetssjukhuset i Linköping, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Universitetssjukhuset i Linköping, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".